Portopulmonary hypertension in cirrhotic patients: Prevalence, clinical features and risk factors

Experimental and Therapeutic Medicine

Volumn 5, Issue 3, 2013, Pages 819-824

  Chen, Hui Song ^a   Xing, Su Rong ^a   Xu, Wei Guo ^a   Yang, Fan ^a   Qi, Xiao Long ^a   Wang, Le Min ^a   Yang, Chang Qing ^a  

^a TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

Author keywords

Hemoglobin; Liver cirrhosis; Portopulmonary hypertension; Risk factors

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ALBUMIN; ALPHA INTERFERON; BILIRUBIN; C REACTIVE PROTEIN; FIBRINOGEN; HEMOGLOBIN; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; LIVER CIRRHOSIS; LIVER VEIN THROMBOSIS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PORTOPULMONARY HYPERTENSION; PREVALENCE; PROTHROMBIN TIME; PULMONARY ARTERY; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT;

EID: 84873186066     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.918     Document Type: Article

References (22)

1. Hadengue A, Benhayoun M, Lebrec D and Benhamou J: Pulmonary hypertension complicating portal hypertension: prevalence and relation to splanchnic hemodynamics. Gastroenterology 100: 520-528, 1991.
2. Simonneau G, Galič N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, Gibbs S, Lebrec D, Speich R and Beghetti M: Clinical classification of pulmonary hypertension. J Am Coll Cardiol 43: S5-S12, 2004.
3. Krowka MJ: Hepatopulmonary syndrome versus portopulmonary hypertension: distinctions and dilemmas. Hepatology 25: 1282-1284, 1997.
4. Castro M, Krowka MJ, Schroeder DR, Beck KC, Plevak DJ, Rettke SR, Cortese DA and Wiesner RH: Frequency and clinical implications of increased pulmonary artery pressures in liver transplant patients. Mayo Clinic Proc 71: 543-551, 1996.
5. Kawut SM, Krowka MJ, Trotter JF, Roberts KE, Benza RL, Badesch DB, Taichman DB, Horn EM, Zacks S and KaplowitzN: Clinical risk factors for portopulmonary hypertension. Hepatology 48: 196-203, 2008.
6. Kalambokis GN, Mouzaki A, Rodi M, Pappas K, KorantzopoulosP and Tsianos EV: Circulating endotoxin and interleukin-6 levels are associated with Doppler-evaluated pulmonary vascular resistance in cirrhotic patients. Hepatol Int 6: 783-789, 2012.
7. Shetty K, Rybicki L and Carey WD: The Child-Pugh classification as a prognostic indicator for survival in primary sclerosing cholangitis. Hepatology 25: 1049-1053, 1997.
8. Cotton CL, Gandhi S, Vaitkus PT, Massad MG, Benedetti E, Mrtek RG and Wiley TE: Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates. Liver Transpl 8: 1051-1054, 2002.
9. Sciomer S, Magrì D and Badagliacca R: Non-invasive assessment of pulmonary hypertension: Doppler-echocardiography. Pulm Pharmacol Ther 20: 135-140, 2007.
10. Krowka MJ: Evolving dilemmas and management of portopulmonary hypertension. Semin Liver Dis 26: 265-272, 2006.
11. Golbin JM and Krowka MJ. Portopulmonary hypertension. Clin Chest Med 28: 203-218, 2007.
12. Scapellato F, Temporelli PL, Eleuteri E, Corrà U, Imparato A and Giannuzzi P: Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic heart failure. J Am Coll Cardiol 37: 1813-1819, 2001.
13. Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA and Lester SJ: A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 41: 1021-1027, 2003.
14. Farzaneh-Far R, McKeown BH, Dang D, Roberts J, SchillerNB and Foster E: Accuracy of Doppler-estimated pulmonary vascular resistance in patients before liver transplantation. Am J Cardiol 101: 259-262, 2008.
15. Kim W, Krowka MJ, Plevak DJ, Lee J, Rettke SR, Frantz RP and Wiesner RH. Accuracy of Doppler echocardiography in the assessment of pulmonary hypertension in liver transplant candidates. Liver Transpl 6: 453-458, 2000.
16. Chemla D, Castelain V, Humbert M, Hébert JL, Simonneau G, Lecarpentier Y and Hervé P: New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 126: 1313-1317, 2004.
17. Robalino BD and Moodie DS: Association between primary pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol 17: 492-498, 1991.
18. Benjaminov F, Prentice M, Sniderman K, Siu S, Liu P and WongF: Portopulmonary hypertension in decompensated cirrhosis with refractory ascites. Gut 52: 1355-1362, 2003.
19. Hoeper MM, Krowka MJ and Strassburg CP: Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 363: 1461-1468, 2004.
20. Humbert M, Sitbon O, Chaouat A, Bertocchi M, Habib G, GressinV, Yaici A, Weitzenblum E, Cordier JF and Chabot F: Pulmonary arterial hypertension in France. Am J Respir Crit Care Med 173: 1023-1030, 2006.
21. Lai K, McFadzean A and Yeung R: Microembolic pulmonary hypertension in pyogenic cholangitis. Br Med J 1: 22-24, 1968.
22. Groszmann RJ: Hyperdynamic circulation of liver disease 40 years later: pathophysiology and clinical consequences. Hepatology 20: 1359-1363, 1994.